NeoGenomics, Inc. (OTC BB: NGNM) is known as the only publicly-traded pure-play laboratory testing service provider that has a specific focus on high revenue cancer genetics testing. The combination of advances in technology and genetic research, with the complete sequencing of the human genome, sophisticated new scientific testing tools to diagnose and treat diseases have been made possible. The company’s two facilities in Ft. Myers, Fla., and other facilities in Nashville, Tenn. and Irvine, Calif provide state of the art genetic testing. For further information, visit the Company’s web site at www.neogenomics.org.
- 17 years ago
QualityStocks
NeoGenomics, Inc. (OTC BB: NGNM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Ramps Up Innovation, Logistics to Power Growth
Massimo (NASDAQ: MAMO) is making strategic moves to actively enhance its position in the powersports and…
-
QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Unveils Significant Resource Estimate at Storm Copper Project
Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a mineral exploration company focused on high-grade metals deposits,…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Expands Portfolio with Additional Solar Project in Upstate New York
SolarBank is developing a 4.584 MW DC ground-mount solar project in upstate New York, projected…